Project
A 24 weeks activity program in patients with early breast cancer receiving aromatase inhibitor therapy. A multicenter randomized phase III trial.
Completed · 2019 until 2023
Rordorf Tamara, Breuss Kim, Quinter Janine
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2019
End Date
2023
Financing
SAKK
Labels
breast cancer